{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:06:36Z","timestamp":1774422396859,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001320","name":"Roswell Park Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2P30CA016056"],"award-info":[{"award-number":["2P30CA016056"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clml.2025.08.019","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:35:00Z","timestamp":1756308900000},"page":"e57-e61.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association and Prognostic Significance of Comorbidities in Individuals With MGUS"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0284-5547","authenticated-orcid":false,"given":"Sawyer","family":"Bawek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nour","family":"Nassour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4590-8997","authenticated-orcid":false,"given":"Malak","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Hutson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Parker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph D.","family":"Tario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott I.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip L.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Hillengass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3948-2070","authenticated-orcid":false,"given":"Janine M.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clml.2025.08.019_bib0001","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4065\/mcp.2010.0520","article-title":"Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence","volume":"85","author":"Rajkumar","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.clml.2025.08.019_bib0002","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3324\/haematol.2009.010066","article-title":"Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study","volume":"94","author":"Kristinsson","year":"2009","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.clml.2025.08.019_bib0003","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance","volume":"378","author":"Kyle","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.clml.2025.08.019_bib0004","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.3324\/haematol.2023.283191","article-title":"Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study","volume":"108","author":"Sigurbergsd\u00f3ttir","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2025.08.019_bib0005","doi-asserted-by":"crossref","DOI":"10.1590\/1980-220x-reeusp-2020-0162","article-title":"Association of the Charlson index with risk classification, clinical aspects, and emergency outcomes","volume":"56","author":"Jesus","year":"2022","journal-title":"Rev Esc Enferm USP"},{"issue":"7","key":"10.1016\/j.clml.2025.08.019_bib0006","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1038\/bjc.2012.46","article-title":"Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality","volume":"106","author":"Jorgensen","year":"2012","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clml.2025.08.019_bib0007","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1038\/s41467-023-39282-y","article-title":"Longitudinal body mass index and cancer risk: a cohort study of 2.6 million Catalan adults","volume":"14","author":"Recalde","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.clml.2025.08.019_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.58585","article-title":"Cumulative excess body mass index and MGUS progression to myeloma","volume":"8","author":"Liu","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.clml.2025.08.019_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2011.34","article-title":"Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score","volume":"1","author":"Kleber","year":"2011","journal-title":"Blood Cancer J"},{"issue":"6","key":"10.1016\/j.clml.2025.08.019_bib0010","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/ejh.13597","article-title":"Comorbidities in multiple myeloma and implications on survival: a population-based study","volume":"106","author":"Sverrisdottir","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2025.08.019_bib0011","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1200\/JCO.2024.42.16_suppl.7551","article-title":"Uncontrolled diabetes mellitus and the progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans","volume":"42","author":"Liu","year":"2024","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clml.2025.08.019_bib0012","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1182\/bloodadvances.2023011608","article-title":"Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population","volume":"8","author":"Joseph","year":"2024","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.clml.2025.08.019_bib0013","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41375-023-01874-4","article-title":"Dietary and microbiome evidence in multiple myeloma and other plasma cell disorders","volume":"37","author":"Shah","year":"2023","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.clml.2025.08.019_bib0014","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1210\/clinem\/dgad450","article-title":"New Horizons: epidemiology of obesity, diabetes mellitus, and cancer prognosis","volume":"109","author":"Harborg","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.clml.2025.08.019_bib0015","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3324\/haematol.2021.278772","article-title":"Diabetes mellitus and risk of plasma cell and lymphoproliferative disorders in 94,579 cases and 368,348 matched controls","volume":"107","author":"Shah","year":"2022","journal-title":"Haematologica"},{"issue":"16_suppl","key":"10.1016\/j.clml.2025.08.019_bib0016","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1200\/JCO.2024.42.16_suppl.7551","article-title":"Uncontrolled diabetes mellitus and the progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans","volume":"42","author":"Liu","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clml.2025.08.019_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(14)00037-4","article-title":"Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study","volume":"2","author":"Chang","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.clml.2025.08.019_bib0018","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1182\/blood-2024-206113","article-title":"Increased incidence of non-hamatologic malignancy in patients with monoclonal gammopathy of undertermined signficance","volume":"144","author":"Flippos","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.clml.2025.08.019_bib0019","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jamainternmed.2022.6117","article-title":"Healthy eating patterns and risk of total and cause-specific mortality","volume":"183","author":"Shan","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"15","key":"10.1016\/j.clml.2025.08.019_bib0020","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2011-05-355743","article-title":"Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)","volume":"118","author":"Mailankody","year":"2011","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025028885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025028885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:15:28Z","timestamp":1772896528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025028885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2152265025028885"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.08.019","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association and Prognostic Significance of Comorbidities in Individuals With MGUS","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}